The Rise of Oral Clinical Nutrition Supplements Market Dynamics and Opportunities 2023-2033

By 2033, the global oral clinical nutrition supplement market is expected to reach US$ 19613.1 million, surpassing US$ 10788.70 million in 2023. A CAGR of 6.2% indicates positive market growth over the forecast period.

The rising demand for oral clinical supplements is attributable to a higher focus on maintaining strong immunity. The demand in the oral clinical nutrition supplement market is poised to surge. Its applications in tackling the issue of malnutrition may aid the overall growth of the oral clinical nutrition supplement market.

Several oral clinical nutrition supplement manufacturers are introducing new flavors to attract a more consumer base. This may remain one of the key factors spurring growth in the market.

Unlock Insights – Request Your Report Sample Today! https://www.futuremarketinsights.com/reports/sample/rep-gb-9486

Key Countries Covered: USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey.etc

Competitive Landscape: Top Manufacturers of Oral Clinical Nutrition Supplement Market and their Recent Developments

Some of the key players in the oral clinical nutrition supplement market are: NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG., Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., GlaxoSmithKline plc, Nestlé S.A., Kate Farms, Inc., Perrigo Company plc, Sichuan Kelun Pharmaceutical Co., Ltd., AYMES International Ltd., Pfizer Inc., Medifood GmbH, Nature’s Bounty Inc., Pharmavite LLC.

Recent Development

The key players are mainly focusing on strategies that may help them increase their market share and gain a competitive advantage.

For instance:

• PediaSure Harvest and Ensure Harvest products were relaunched in September 2021 with organic ingredients and plant-based protein. Nutritional supplements can be used to meet the daily nutritional needs of individuals or as a sole source of nutrition.
• Persona, a company that offers personalized vitamins, was acquired by Nestlé Health Science in August 2019. As a result of this acquisition, the company would be able to expand its personalized nutrition business.
• In Feb 2019, Matok V’Kal launched its stamina boost-up spray which contains no caffeine and only six calories
• In Apr 2019, PRO-DIP introduced its oral clinical nutritional supplement a revolutionary pouch that provides energy and nutrition in small, semi-permeable sachets.
• In Apr 2018, Abbott introduced Ensure Max which is a nutritional drink with high-quality proteins and a very low amount of sugar.

Global Oral Clinical Nutrition Supplement Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The Food and Drug Administration (FDA) has narrowly restricted illegal claims on diseases and health maintenance provided by the oral clinical nutrition supplement manufacturers on their products. Manufacturers who want to sell their oral clinical nutrition supplements with disease claims must get them approved by FDA.

According to FMI’s analysis, oral clinical nutrition supplement sales have grown at a CAGR of more than 5.0% between 2017 and 2022. The rising interest of consumers in oral clinical nutrition supplements is providing impetus to the growth registered.

This has also encouraged manufacturers to participate in research and development (R&D) activities. Some scientists are investigating whether increasing the quality of certain nutrients, such as vitamin C and vitamin E, with food additives such as probiotics or beyond the Prescribed Dietary Allowances (RDA), could improve bone health, especially in the elderly.

This will also help the market is gaining traction. FMI projects that global oral clinical nutrition supplements grow at a CAGR of around 6.2% through 2033.

• Short Term (2022 to 2025): The short-term growth prospects of the market are likely to grow as there could be increased research and development of new oral clinical nutrition supplements, particularly those that are tailored to the needs of specific patient populations or medical conditions.
• Medium Term (2025 to 2028): The market is likely to show a slight uptake as it could be increased awareness and adoption of these supplements among healthcare professionals and patients.
• Long Term (2028 to 2033): The long-term goal for the oral clinical nutrition supplement market could involve collaborations between pharmaceutical companies, healthcare providers, and academic researchers to identify gaps in the market and develop innovative new products to fill those gaps.

Our Experts Provide You Customized Reports: https://www.futuremarketinsights.com/customization-available/REP-GB-9486

Oral Clinical Nutrition Supplement Market Category-wise Insights

Why is Standard Oral Nutrition Supplement Formula Preferred More?

FMI estimates that in the product type segment standard formula oral clinical nutrition supplements are holding more than 60% of the market share with a CAGR of 6.2%.

The standard formula is consumed for several types of diseases/indications while specialized formula is specially developed to treat a patient suffering from a particular disease or a specific condition. This has resulted in higher consumption of the standard formula.

Why is General Well-being Considered Leading Indication?

Oral nutrition supplements are often taken for general well-being, catapulting it as the leading segment within the market in terms of indication. General well-being is projected to remain dominant through the course of the forecast period. It is likely to account for nearly 20% of sales registered.

Increasing focus on maintaining good health and immune systems among consumers will seal dominance of this segment through the forecast period.

How is the Market Gaining from Rising Demand for Geriatric Population?

The geriatric population has emerged as the leading end user of oral clinical nutrition. The geriatric population segment may account for over 40% of sales through the forecast period.

Low immunity in aged people can trigger various health issues. This makes the geriatric population, key end users of oral clinical nutrition supplements.

What Is the Future of Liquid Form Oral Clinical Nutrition Supplements?

Liquid-form oral clinical nutrition supplements currently account for a dominant 40% of the market and are expected to remain the leading segment in terms of form through the forecast period. Increasing the launch of oral clinical nutrition formulas in liquid form may continue aiding growth in this segment with a CAGR of 7.2%

Which is the Preferred Oral Clinical Nutrition Supplement Flavor?

Flavored oral clinical nutrition supplements currently hold more than 70% market share. In the flavored segment, chocolate-flavored oral clinical nutrition supplements are highly sought-after.

Which is the Preferred Sales Channel for Oral Clinical Nutrition Supplement Market?

Prescription-based channels are responsible for more than 90% of sales of oral clinical nutrition supplements around the world. Oral clinical nutrition supplements are often administered as per the dosage prescribed by doctors. This is expected to aid expansion within the sales channel.

Maximize growth potential! Grab your discounted report today https://www.futuremarketinsights.com/checkout/9486

Oral Clinical Nutrition Supplement Market Segmentation by Category

Product Type:

• Standard Formula
• Specialized Formula

Indication:

• General Well-being
• Renal Disorders
• Hepatic Disorders
• Oncology Nutrition
• Diabetes
• Dysphagia
• IBD & GI Tract Disorders
• Neurological Disorders
• Respiratory Orders
• Others

Form:

• Liquid
• Semi-solid
• Powder

End User:

• Adult
• Geriatric
• Pediatric

Flavor:

• Regular
• Flavored
  • Chocolate
  • Vanilla
  • Strawberry
  • Apple
  • Mixed Berries
  • Orange
  • Nut Flavours

Channel:

• Prescription-based
• Over-the-Counter
  • Modern Trade
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• The Middle East and Africa
• East Asia

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube